ResMed | RMD - Koszty Sprzedaży I Administracji





Koszty Sprzedaży I Administracji Zmiana Data
Ansell USD 274.8M 7.6M 2025-12
Artivion USD 55.75M 4.54M 2025-12
AtriCure USD 82.56M 1.99M 2026-06
Baxter International USD 735M 7M 2026-06
Cochlear AUD 449.4M 214.45M 2025-12
Cooper Companies USD 676.2M 303.1M 2026-03
CSL USD 1.23B 498M 2025-12
Dexcom USD 358.7M 9M 2026-06
Edwards Lifesciences USD 561.2M 39M 2026-06
Fisher Paykel Healthcare NZD 312.7M 27.2M 2026-06
Globus Medical USD 286.82M 10.95M 2026-06
Haemonetics USD 118.94M 1.99M 2026-06
Idexx Laboratories USD 288.09M 11.76M 2026-06
Inogen USD 43.77M 510K 2024-06
Insulet USD 344.8M 27.6M 2026-06
Integra LifeSciences USD 166.22M 12.01M 2026-06
Intuitive Surgical USD 617.9M 4.6M 2026-06
Medtronic 2.96B 9M 2025-12
Philips EUR 1.21B 23M 2026-06
Ramsay Health Care AUD 5.29B 3.2M 2024-12
ResMed USD 290.65M 10.86M 2026-06
Sigma Healthcare AUD 134.77M 9.73M 2024-12
Sonic Healthcare AUD 2.52B 2.46B 2024-12
Steris USD 369.7M 17.9M 2026-06
Teleflex USD 213.52M 12.5M 2026-06
Thermo Fisher Scientific USD 1.91B 111M 2026-06